 |
|
 |
 |
 |
Surgeons-in-training dislike new work hours: survey
By Andrew M. Seaman NEW YORK (Reuters Health) - Most surgeons-in-training dislike new rules that limit how many hours they can work, according to a new study that also found the majority said they skirt the restrictions. Researchers surveyed 1,013... |
|
Patenting genes: Justices tackle big health issue
WASHINGTON (AP) — The Supreme Court seemed worried Monday about the idea of companies patenting human genes in a case that could profoundly reshape the multibillion-dollar biomedical industry and U.S. research in the fight against diseases like br... |
|
FDA reviewers say data for Glaxo's Breo not consistent
WASHINGTON (Reuters) - Reviewers for the U.S. Food and Drug Administration said on Monday that the efficacy data for GlaxoSmithKline Plc and Theravance Inc's experimental drug to treat chronic obstructive pulmonary disease are not entirely con... |
|
GSK plans $1 million prize to jump-start "electroceuticals"
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said on Wednesday it would offer ... |
|
Oklahoma warns 7,000 dental patients of HIV, hepatitis risk
By Steve Olafson OKLAHOMA CITY (Reuters) - Health officials are notifying some 7,000 people to warn they may have been exposed to HIV and other infectious diseases at an Oklahoma dental practice where improper sterilization procedures and rusty su... |
|
Shire boosts rare diseases business by buying Premacure
LONDON (Reuters) - Shire increased its investment in rare diseases on Tuesday by acquiring privately held Swedish biotech firm Premacure, which is developing a drug for a potentially blinding eye disorder in premature babies. Britain's third b... |
|
Butchers enjoy sales boost after horsemeat furore
LONDON (Reuters) - In one of Britain's oldest butcher's shops, staff in straw hats are rushing to cope with a surge in demand for pricey pies and sausages from customers worried about a scandal over mislabelled horsemeat and rich enough to... |
|
Sanofi says Gaucher pill studies meet goals
PARIS (Reuters) - Sanofi said its experimental pill for Gaucher disease met its main targets in two late-stage studies, which the French drugmaker will use to bolster its case for regulatory approval. Eliglustat tartrate could become the first ora... |
|
Lombard Medical Tech wins U.S. nod for aortic stent
LONDON (Reuters) - Lombard Medical Technologies has won United States approval for its device to treat abdominal aortic aneurysm (AAA), giving it access to the world's largest market for the product and boosting its shares by 31 percent. The A... |
|
|
 |
